1. USP4 boosts gastric cancer cell growth and glucose metabolism by deubiquitinating and increases the stability of PKM2.2. The USP4 enzyme acts as an oncoprotein in gastric cancer and controls NF-kappaB signaling by regulating PRL-3 expression. Here, USP4 is linked to gastric cancer.